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Gastrulation is a morphogenetic process in which
tightly coordinated cell and tissue movements estab-
lish the three germ layers (ectoderm, mesoderm, and
endoderm) to define the anterior-to-posterior embry-
onic organization [1]. To elicit this movement, cells
modulate membrane protrusions and undergo dy-
namic cell interactions. Here we report that ankyrin re-
peats domain protein 5 (xANR5), a novel FGF target
gene product, regulates cell-protrusion formation
and tissue separation, a process that develops the
boundary between the ectoderm and mesoderm [2,
3], during Xenopus gastrulation. Loss of xANR5 func-
tion by antisense morpholino oligonucleotide (MO)
caused a short trunk and spina bifida without affect-
ing mesodermal gene expressions. xANR5-MO also
blocked elongation of activin-treated animal caps
(ACs) and tissue separation. The dorsal cells of xANR5-
MO-injected embryos exhibited markedly reduced
membrane protrusions, which could be restored by
coinjecting active Rho. Active Rho also rescued the
xANR5-MO-inhibited tissue separation. We further
demonstrated that xANR5 interacted physically and
functionally with paraxial protocadherin (PAPC),
which has known functions in cell-sorting behavior,
tissue separation, and gastrulation cell movements
[4–6], to regulate early morphogenesis. Our findings
reveal for the first time that xANR5 acts through Rho
to regulate gastrulation and is an important cytoplas-
mic partner of PAPC, whose cytoplasmic partner was
previously unknown.
Results and Discussion
XL023o21, which Encodes Ankyrin Repeats Domain
Protein 5, Is a Novel FGF Target
We previously performed a screening with dorsal mar-
ginal zone (DMZ) explants treated with the FGF receptor
inhibitor SU5402. From this screen, XL023o21 was
isolated as a downregulated gene [7]. In the DMZ, the
endogenous expression of XL023o21 was suppressed
by a dominant-negative FGFR (XFD) or by SU5402 to
the background level. Overexpression of eFGF caused
the upregulation of XL023o21, which was suppressed
*Correspondence: nueno@nibb.ac.jpby SU5402 treatment. The ectopic expression of eFGF
in ACs upregulated XL023o21 expression in a concen-
tration-dependent manner, and this increase was down-
regulated by SU5402 (Figures 1A and 1B). These data
indicate that XL023o21 is an FGF-responsive gene.
XL023o21 encodes ankyrin repeats domain protein 5
(xANR5), which has two predicted functional domains
(Figure 1C): both ends contain ankyrin repeats, which
act as a scaffold for protein interactions and cytoskele-
ton binding [8], and the intermediate region contains two
EF-hand domains that bind calcium and modulate cal-
cium signaling [9]. BLAST and XDB (http://Xenopus.
nibb.ac.jp) searches showed that ANR5 is well con-
served across vertebrates, suggesting that it has an
evolutionarily important role during development. The
Xenopus ANR5 and human ANR5 amino acid sequences
show 53% identity and 70% similarity overall (Figure 1C).
In addition, xANR5 shows 86% identity to its ortholog in
Xenopus tropicalis (data not shown). xANR5 is mater-
nally expressed during early embryogenesis, and its
transcripts are almost ubiquitous but dorsally enriched
in the gastrula (Figures S1A and S1B in the Supplemen-
tal Data available online). Intriguingly, the expression
patterns of PAPC, Fz7, and Rho [5, 10] overlapped
with that of xANR5 in the dorsal mesoderm, suggest-
ing that these molecules might function in similar
processes.
xANR5-MO Perturbs Early Embryonic Development
To elucidate the function of xANR5 during gastrulation,
we performed gain- and loss-of-function analyses.
Microinjection of xANR5 mRNA or xANR5-MO that spe-
cifically suppressed the expression of UTR-xANR5-Vns
(Figure 1D) caused incomplete blastopore closure
(data not shown) and a short trunk and spina bifida
(S. B.) at the tadpole stage (Figure 1E). Remarkably,
the morphological defects caused by xANR5-MO were
rescued by the coinjection of xANR5, a rescue construct
lacking the MO recognition site, or of hANR5 mRNA
coinjection (Figure 1E). These results indicate that the
phenotype was specifically due to xANR5 depletion
and that ANR5’s function is conserved across phylog-
eny. Despite the morphological defects, however, em-
bryonic induction and patterning were not disturbed
in the xANR5 mRNA- or xANR5-MO-injected embryos
(Figures S2A–S2E).
We further demonstrated that xANR5-MO inhibited
the elongation of activin-treated ACs without affecting
mesodermal induction (Figure S2E), and this MO-
induced inhibition was also efficiently rescued by the
overexpression of hANR5 (Figure 1F). These data indi-
cate again that the effect of xANR5-MO was not due to
impaired mesodermal formation but rather due to a de-
fect in cell movement. Further evidence for the function
of xANR5 in regulating early morphogenetic movements
was obtained by analyzing early gastrula that were fixed
and sectioned sagittally along the dorsal midline. In the
Xenopus gastrula, involuted mesodermal cells migrate
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(A and B) XL023o21 was upregulated by the overexpression of eFGF (10, 100 pg) and downregulated by the inhibition of FGF signaling with XFD
(500 pg) or SU5402 (25, 50 mM). The results of three experiments are shown. Error bars indicate standard deviation from three different data.
(C) Comparison of the protein structures of human ANR5 (hANR5) and Xenopus ANR5 (xANR5). The numbers above and inside the box indicate
the amino acid residues and the percent identity between the two proteins, respectively.
(D) The effect of xANR5-MO on the transcription of xANR5mRNA was demonstrated with an in vitro transcription/translation system. xANR5-MO
specifically inhibited the transcription of the UTR-including xANR5 mRNA (UTR-xANR5-Vns) constructed to generate a fusion protein with eYFP
(Vns). The effect of xANR5-MO was restored by coexpression of a rescue construct (rescue-xANR5-Vns). xANR5 protein was detected by west-
ern blotting with an anti-GFP antibody. Vns protein was detected as a loading control.
(E) Depletion of xANR5 by MO (16.8 ng per embryo) or the overexpression of xANR5 resulted in a short trunk (short) and S.B. These gastrulation-
defective phenotypes caused by xANR5-MO were partially restored by the coinjection of xANR5, a rescue construct (500 pg), or hANR5 (400 pg).
(F) When coinjected with activin, xANR5-MO abrogated the activin-induced elongation of animal caps, which was fully rescued by the coinjection
of hANR5. 20 embryos that had received a microinjection of mRNA or MOs were used for AC isolation at the blastula stage. Ten explants each
were used to examine activin-induced elongation and for RT-PCR analysis. The data represent three different experiments.
(G) Schematic diagram of a sagittally fractured early gastrula shows the tissue separation at the DMZ, indicated by the visually identifiable
Brachet’s cleft. Black arrows indicate the anterior and posterior ends of the cleft, respectively. Embryos fixed at stage 10.5 were fractured
through the dorsal blastopore, and the Brachet’s cleft formation was analyzed. The Con-MO-injected embryo showed a cleft that extended
from the anterior to posterior end, whereas the xANR5-MO-injected embryo showed perturbed posterior cleft formation. Coinjection of a rescue
construct restored the extension of the posterior cleft that was inhibited by xANR5-MO microinjection.away from the blastopore toward the animal pole by
crawling on the blastocoel roof (BCR), which consists
of noninvoluting ectodermal cells. The development
of a morphologically identifiable boundary or cleft(Brachet’s cleft) between the mesodermal and ectoder-
mal layer prevents their cells from intermingling [2, 3].
Notably, in the embryos that received an xANR5-MO
injection, the boundary between the BCR and the
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Protrusive Morphology
(A and B) The dorsal marginal zone (DMZ) of
an embryo that had received a microinjection
of MO or mRNA at the 4-cell stage was iso-
lated at stage 10.5 and dissociated in
CMFM. Dissociated dorsal cells were plated
on a fibronectin-coated glass-bottomed
dish, and their spreading on fibronectin was
observed after a 1 hr incubation in Stein-
berg’s solution. Unattached cells were re-
moved by gentle washing. Con-MO-injected
cells were well spread on the fibronectin
and produced fully formed filopodial and
lamellipodial protrusions. Membrane blebs
were hardly observed in the Con-MO-
injected cells. Most of the xANR5-MO-
injected cells failed to spread on fibronectin
and showed far fewer active protrusions
and a higher frequency of membrane blebs
than the Con-MO-injected cells. The coinjec-
tion of xANR5 or CARho (2.5 pg) could
partially and almost completely reverse the
effects caused by xANR5-MO, respectively.
The white and yellow arrows indicate filo-
podia and lamellipodia, respectively. Arrow-
head indicates a membrane bleb. Error bars
indicate standard deviation from three differ-
ent data. Scale bar represents 50 mm.
(C) The DMZ and ventral marginal zone (VMZ)
of embryos that had received a microinjection
of MO or mRNA were isolated at stage 10.5
and subjected to a Rho activation assay.
Overexpression of xANR5 (1 ng) increased
the Rho activity in the VMZ, whereas
xANR5-MO downregulated the activation of
Rho in the DMZ.
(D) DMZ cell dissociation and reaggregation
assay. Cells from DMZs of Con-MO-injected
embryos formed a large cell mass upon cal-
cium addition while those from xANR5-MO
injected embryos failed to reaggregate,
which was rescued by the coinjection of
xANR5.involuted mesoderm disappeared posteriorly, and
Brachet’s cleft was present only anteriorly. This result
implies that tissue separation is abrogated by the
knocking down of xANR5 expression. The inhibition of
the cleft extension caused by xANR5-MO was specific,
because the coinjection of a rescue construct (xANR5)
led to a well-developed posterior cleft (Figure 1G).
Depletion of xANR5 Disrupts Cell Spreading
and Cell Protrusion
Gastrulation is a fundamental morphogenetic process
regulated by highly orchestrated movements of cells
and tissues. For this movement to occur, cells must
achieve dynamic modulation of protrusions that are im-
portant for the cell motility [1, 11, 12]. We found that DMZ
in which xANR5 function had been lost did not show
convergent extension (CE) at stage 14, whereas the con-
trol-MO (Con-MO)-injected DMZ showed good CE (Fig-
ure S3A). Furthermore, at an earlier stage (stage 13), the
xANR5-MO-injected dorsal cells failed to become tightly
coordinated and were round in shape. These cells pro-
duced reduced cell protrusions, such as filopodia and
lamellipodia (Figures S3B and S3C). Our data indicatethat xANR5 might modulate the cell protrusions. To
investigate this possibility more directly, we next exam-
ined the morphology at a single-cell level, focusing on
the cell protrusions.
Dorsal cells were dissociated from embryos that had
received MO or mRNA injection and were incubated
for 1 hr on a fibronectin-coated dish, to allow binding.
The morphology of the cells that were attached to the
fibronectin was then observed. Approximately 60% of
the Con-MO-injected cells underwent spreading and
flattening. However, the spreading of the xANR5-MO-
injected cells was dramatically reduced, with only 10%
of the cells showing spreading on fibronectin. The coin-
jection of a rescue construct restored the cell-spreading
effect to the xANR5-MO-injected cells (Figure 2A).
The above results led us to examine the membrane
morphology more closely, to determine whether the
xANR5-MO modifies the dynamic membrane protru-
sions like filopodia and lamellipodia, which allow cell-
shape change and movements, and the loss of whose
function can influence gastrulation [11, 12]. A mem-
brane-bound form of Vns (mbVns) and the actin-binding
domain of a moesin-bound form of RFP (moesin-abdRFP)
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namic movements of the protrusions, we took time-
lapse movies of individual cells. Con-MO-injected cells
produced dynamic protrusions; the filopodia and lamel-
lipodia were well extended and retracted. In contrast, the
xANR5-MO-injected cells showed remarkably fewer and
smaller protrusions, which were static and appeared
frozen on the fibronectin, and actively generated shape-
and location-transforming membrane blebs. The co-
expression of the rescue construct with xANR5-MO
rescued the effect caused by the loss of xANR5 function
and resulted in the production of dynamic membrane
protrusions (Figure 2B and Figure S3D).
It is also well known that protrusive cell morphology is
regulated by the small GTPase Rho family [12–14]. Thus,
we speculated that xANR5 requires the function of small
GTPases for its regulation of cell protrusions. Intrigu-
ingly, the coexpression of a constitutively active form
of Rho (CARho) prevented the reduced protrusions
and increased membrane blebs that were induced by
the loss of xANR5 function (Figure 2B and Figure S3D).
We also found that Rho activity in the DMZ was signifi-
cantly suppressed by xANR5-MO injection. Overexpres-
sion of xANR5 in the VMZ increased the Rho activation
(Figure 2C). Taken together, these results clearly indi-
cate that xANR5 regulates cell morphology by modulat-
ing Rho activity. In addition, these data are consistent
with previous reports showing that the Rho family regu-
lates cell-shape change, adhesion, and migration, which
are mediated by the actin cytoskeleton [12–15]. The co-
injection of a constitutively active form of Rac (CARac)
did not show a significant rescue effect on the protrusive
morphology (data not shown).
xANR5-MO Influences Cell-Cell Adhesion
In our experiments, we noticed that the cells from
xANR5-MO-injected embryos were rounded-up and
loosely packed in dorsal explants (Figure S3B), suggest-
ing that xANR5 might also control cell-cell adhesion. To
test this possibility more directly, we assessed whether
xANR5-MO could modulate cell-cell adhesion by using
a dissociation and reaggregation assay. DMZs from em-
bryos that had received a microinjection of MO or mRNA
were isolated and dissociated in calcium-magnesium-
free medium (CMFM) with gentle shaking. We confirmed
that the explants were well dissociated in CMFM.
Calcium was added, and 2–3 hr later, the cells from the
Con-MO-injected embryos had reaggregated and
formed a large cell mass, whereas those from the
xANR5-MO-injected embryos failed to reaggregate
and remained dispersed (Figure 2D). Again, the co-
expression of xANR5 rescued the effect of xANR5-MO
and resulted in the production of cell clumps. These
results support the idea that xANR5 regulates cell-cell
adhesion.
xANR5 and PAPC Interact Synergistically
in the Formation of Brachet’s Cleft
Rho is known as a cytoskeleton regulator. We found that
Rho can also rescue the impaired cell morphology
caused by xANR5-MO. Recently, Rho was reported to
be involved in the development of Brachet’s cleft [5].
To examine the role of xANR5 and Rho in tissue separa-
tion, xANR5-MO (Figure 1G) andCARhowere coinjectedinto the dorsovegetal side of embryos. Intriguingly, the
CARho-coinjected embryos showed extension of the
posterior cleft, although the effect was partial (Fig-
ure 3A). This result supports the idea that xANR5 and
Rho, whose activity is regulated by xANR5, interact
in tissue separation. The coinjection of CARac with
xANR5-MO failed to reverse the effect of xANR5-MO;
rather, it exacerbated the xANR5-MO effect on the for-
mation of Brachet’s cleft. To examine further whether
xANR5 influences the separation behavior, we carried
out an in vitro tissue-separation assay as described pre-
viously [3, 5]. The coinjection of xANR5-MO abolished
the separation behavior induced by BVg1 overexpres-
sion (Figures S4A–S4C), indicating that xANR5 has
a role in the tissue separation.
It was previously demonstrated that XFz7 and PAPC
enhance tissue separation, and conversely, that the
knockdown of these proteins abolishes the develop-
ment of Brachet’s cleft nonredundantly [3, 5]. We there-
fore reasoned that xANR5 might interact with XFz7 or
PAPC in regulating cleft formation. A low dose of
xANR5-MO that was insufficient to inhibit cleft formation
Figure 3. xANR5-MO Inhibits the Development of Brachet’s Cleft
Embryos that had received a microinjection of MO or mRNA into the
two dorsovegetal blastomeres at the 8-cell stage were fixed at stage
10.5, then sagittally fractured to examine formation of the cleft.
(A) Inhibition of the cleft’s extension caused by xANR5-MO was spe-
cifically rescued by the coinjection of xANR5 mRNA. CARho (10 pg)
could partially rescue the inhibition of the posterior cleft formation
caused by xANR5-MO. However, CARac failed to recover the effect
of xANR5-MO on cleft formation.
(B) A low amount of xANR5-MO (4.2 ng), PAPC-MOs (20 ng), and/or
Fz7-MO (40 ng) was introduced into dorsovegetal blastomeres by
individual injections or coinjection to detect possible interactions
among these molecules. Each MO injected alone resulted in a
near-normal extension of Brachet’s cleft. Coinjection of a low
amount of xANR5-MO and PAPC-MOs caused a synergistic inhibi-
tion of cleft development and caused a severe defect in the posterior
cleft formation, while coinjection of a low amount of xANR5-MO and
Fz7-MO showed an additive effect on cleft formation.
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with PAPC and Indispensable for the PAPC-
Dependent Signaling Pathway
(A) Expression patterns of xANR5 and PAPC
at the early gastrula were detected with Fluo-
rescein-labeled antisense RNA of xANR5
and DIG-labeled antisense RNA of PAPC.
Embryos were fixed at stage 10.5 and sec-
tioned sagittally through the dorsal midline.
xANR5 and PAPC were showed overlapping
expressions at the DMZ. Arrowheads indi-
cate the blastopore.
(B) Full-length xANR5 was tagged with the
6-repeat myc epitope (MT-xANR5), and full-
length PAPC was tagged with the flag epitope
(PAPC-flag). MT-xANR5 (50 pg) and PAPC-
flag (50 pg) were injected into two animal
and dorsal blastomeres at the 2-cell stage
and 4-cell stage and then isolated at the blas-
tula and early gastrula stage, respectively.
xANR5 was detected with a mouse anti-myc
antibody and an Alexa 488-conjugated
mouse anti-IgG antibody. PAPC was de-
tected with a rabbit anti-flag antibody and
an Alexa 544-conjugated rabbit anti-IgG anti-
body. Scale bar represents 50 mm.
(C) Immunoprecipitation experiments with
MT-xANR5 and PAPC-flag were carried out
in 293T culture cells. The expressed proteins
were precipitated with a mouse anti-flag anti-
body (Sigma-Aldrich) and detected with
a rabbit anti-flag antibody (Sigma-Aldrich)
and mouse anti-myc antibody. A physical
interaction between xANR5 and PAPC was
determined by western blotting. An arrow indicates PAPC expression detected with a rabbit anti-flag antibody.
(D) A JNK activation assay was carried out with animal blastomeres. The single injection of PAPC or xANR5 enabled the induction of c-jun phos-
phorylation, and the coinjection of PAPC and xANR5 further increased the c-jun activity. The phosphorylation of c-jun triggered by PAPC over-
expression was significantly decreased when xANR5-MO was coinjected, and this effect was rescued by xANR5 coinjection.
(E) To investigate whether xANR5 is involved in the PAPC-dependent Rho activation, a Rho activation assay was carried out with marginal zone
explants. In the VMZ, the overexpression ofPAPC induced the activation of Rho activity, which was suppressed by the coinjection of xANR5-MO.
(F) The depletion of PAPC by MO injection into the 2 dorsal blastomeres at the 4-cell stage resulted in a short trunk and S.B. Coinjection of xANR5
mRNA into the dorsal cells could partially rescue the effect of PAPC-MOs.was coinjected with a low dose of XFz7-MO or PAPC-
MOs, followed by a careful analysis of the cleft forma-
tion. Surprisingly, when the levels of xANR5 and PAPC
were simultaneously lowered by the coinjection of a
low amount of each MO, cleft formation was synergisti-
cally inhibited; the extension of the posterior cleft was
absent in approximately 50% of the embryos, and only
about 20% of the embryos showed a wild-type cleft (Fig-
ure 3B). However, the coinjection of low doses of
xANR5-MO and XFz7-MO showed only an additive ef-
fect on the cleft formation, suggesting that xANR5 and
XFz7 do not functionally interact. This result was some-
what unexpected, because a previous report showed
that the coinjection of low amounts of PAPC-MO and
XFz7-MO synergistically inhibited cleft formation, sug-
gesting that these proteins had nonredundant functions.
One explanation for the discrepancy is that cytoplasmic
complexes or partners of these molecules might modu-
late or fine-tune each pathway. The tissue separation
induced by XFz7 and PAPC requires, respectively,
PKC-a activity and Rho activity. However, XFz7-depen-
dent PKC-a activity does not participate in the PAPC-
dependent tissue separation [3, 5]. Our findings demon-
strating that xANR5-MO and PAPC-MOs, but not
xANR5-MO and XFz7-MO, have a synergistic effect on
the development of Brachet’s cleft imply that xANR5interacts functionally with PAPC in the regulation of
tissue separation. Consequently, we suggest that
xANR5 might modulate PAPC function in the regulation
of gastrulation.
xANR5 Is Colocalized and Physically Interacted
with PAPC
To determine whether xANR5 and PAPC form a complex
as binding partners, we first examined the embryonic
localization of these two molecules. We performed
whole-mount in situ hybridization (WISH) and analyzed
the expression patterns of xANR5 and PAPC at the gas-
trula stage. Embryos fixed at the gastrula stage were
fractured sagittally and subjected to the WISH with a
Fluorescein-labeled antisense xANR5 probe (xANR5-
Fluorescein) and DIG-labeled antisense PAPC probe
(PAPC-DIG) or vice versa. The embryos showed over-
lapping expression patterns of xANR5 and PAPC in the
DMZ (Figure 4A). Next, we examined the subcellular
localization of xANR5 and PAPC in ACs and the DMZ
with a 6-repeat myc epitope-tagged xANR5 (MT-xANR5)
and flag epitope-tagged PAPC (PAPC-flag). The locali-
zation of the two epitope-tagged proteins was detected
by immunostaining. In ACs, xANR5 (green) was localized
to the cytoplasm, apparently near the plasma mem-
brane. In the spindle-shaped dorsal cells, xANR5
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lipodial activity orchestrates directional cell movements
[11] (Figure 4B). These results were consistent with the
localization of xANR5-Vns (Figure S1C). The expression
of PAPC (red) was detected near the membrane and at
the two tips of bipolarized cells in the AC and DMZ,
respectively, as reported previously [6]. In a merged im-
age, the colocalization of xANR5 and PAPC (yellow) was
clearly detected near the cell membrane. Notably, in the
spindle-shaped dorsal cells, both xANR5 and PAPC
were concentrated at the two tips, where they showed
overlapping expression (Figure 4B).
To examine the interaction of these two proteins more
directly, we performed coimmunoprecipitation and pull-
down assays with epitope-tagged proteins. We demon-
strated that MT-xANR5 and PAPC-flag interacted in the
immunoprecipitation assay (Figure 4C), and we con-
firmed the physical interaction of xANR5 and PAPC in
a GST pull-down assay (Figure S5A). The physical inter-
action was specific, because we failed to detect any
interaction between MT-xANR5 or xANR5-GST and the
flag epitope alone. To identify which domain of xANR5
is required for this association, we made several dele-
tion constructs of xANR5 fused with the GST epitope.
Among the domains of xANR5, we identified the C-ter-
minal ankyrin repeats domain as the mediator of the
physical interaction of xANR5 and PAPC (Figure S5A).
Our findings suggest that PAPC and xANR5 have co-
operative roles in gastrulation and further imply that the
C-terminal ankyrin repeats domain might be critical in
bridging the function of these two proteins. Roles of
the cadherin superfamily during embryonic develop-
ment have been extensively demonstrated [4–6, 16–19];
classical cadherins, which form cytoplasmic complexes
with catenins, mediate diverse cell and tissue move-
ments. The protocadherin family is also known to regu-
late tissue morphogeneses such as tissue separation,
gastrulation cell movements, and neural fold formation
during embryogenesis. However, unlike classical cad-
herins, little is known about the cytoplasmic partners
or complexes of protocadherin. This is the first report
that xANR5, a novel FGF target protein, forms a cyto-
plasmic complex through its C-terminal ankyrin repeats
domain with PAPC, a member of the protocadherin
family.
xANR5 Is Indispensable for the PAPC-Regulated
Signaling Pathways
The results obtained above led us to speculate further
that xANR5 might regulate PAPC-mediated signaling
pathways. PAPC was recently proposed to have a sig-
naling function in regulating JNK and Rho [5, 6], which
are important molecular components of the PCP path-
way [20, 21]. First, we examined whether xANR5 is
involved in the regulation of PAPC-dependent JNK
activity. The MO and/or mRNA were coinjected with a
GAL4-DBD-bound form of c-jun into two animal blasto-
meres at the 2-cell stage. JNK activity was detected by
c-Jun phosphorylation. The overexpression of PAPC
produced c-Jun phosphorylation, consistent with previ-
ous reports [5, 6]. The overexpression of xANR5 also
increased the JNK activity. Furthermore, the c-Jun phos-
phorylation was much more enhanced by the coinjec-
tion of xANR5 and PAPC than by a single injection ofxANR5 or PAPC. When PAPC and xANR5-MO were si-
multaneously introduced into the animal blastomeres,
interestingly, xANR5-MO inhibited the c-Jun phosphor-
ylation caused by PAPC overexpression, which in turn
implies that xANR5-MO abrogated the PAPC-mediated
JNK activation. The effect of xANR5-MO on this c-Jun
phosphorylation was specific, because the coinjection
of xANR5 could increase the JNK activity in the presence
of xANR5-MO (Figure 4D).
Next, we carried out a Rho activation assay and exam-
ined whether xANR5-MO, which can also downregulate
Rho activity in the DMZ, inhibits PAPC-dependent Rho
activation. Microinjection of PAPC into the two ventral
blastomeres at the 4-cell stage triggered the activation
of Rho in the VMZ, where the activity is normally lower
than in the DMZ [21, 22]. However, the ectopic Rho activ-
ity was reduced when xANR5-MO was coinjected with
PAPC (Figure 4E). We further examined whether
xANR5 could rescue the downregulated Rho activity
by PAPC-MO injection in the DMZ. The innate Rho activ-
ity in the DMZ was reduced when PAPC-MO was
injected into the two dorsal blastomeres at the 4-cell
stage. The downregulated Rho activity was completely
restored by the coinjection of xANR5, suggesting that
xANR5 modulates the PAPC-regulated Rho activation
(Figure S5B).
The importance of JNK and the Rho family proteins in
cell and tissue movements is well conserved across
phylogeny [12–14, 20–23]. These proteins are critical
elements of the cellular machinery associated with
polarized cell motility and cytoskeletal behavior. Recent
reports showed that PAPC modulates Rho activation,
whose activity regulates not only cell movements but
also tissue separation, and our findings were reminis-
cent of these observations. When xANR5-MO was
injected into the dorsal region, we found defects in pro-
trusive cell morphology and gastrulation cell move-
ments. In these DMZs, the Rho activity was remarkably
reduced and the formation of Brachet’s cleft was
inhibited. In addition, the inhibition of the cleft was
exacerbated by the coinjection of xANR5-MO and
PAPC-MOs. Taken together, the finding that xANR5-
MO inhibited PAPC-dependent JNK and Rho activation
supports the idea that xANR5 is required for cytoskeletal
remodeling and cellular locomotion in PAPC-elicited
intracellular responses.
Finally, we performed an embryonic rescue experi-
ment to determine whether xANR5 could compensate
for the effect caused by the PAPC-MOs. The microinjec-
tion of PAPC-MOs into the two dorsal blastomeres at the
4-cell stage produced phenotypes such as a short trunk
and S.B. Interestingly, the coexpression of xANR5
mRNA restored the phenotypes caused by the PAPC
knockdown, although this was a partial effect (Figure 4F).
This rescue effect was also confirmed for the Rho activ-
ity (Figure S5B). These results clearly indicate that
xANR5 plays an important role in the PAPC-dependent
signaling pathways that regulate morphogenetic
processes.
Conclusions
Our study shows that xANR5, which was identified from
a microarray analysis with SU5402-treated DMZs, regu-
lates cell-protrusive morphology and tissue separation
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that xANR5 functions in regulating early morphogenetic
movements. The expression of xANR5 is enriched in
DMZ and in the two tips of spindle-shaped dorsal cells,
where extensive cell and tissue movements occur.
xANR5 is colocalized with PAPC, which is known to reg-
ulate gastrulation cell movements and tissue separa-
tion. xANR5-MO caused defects in the cell-protrusive
morphology that is critical for the dynamic cell-shape
changes and cell motility by inhibiting Rho activity. In
our previous report [12], we demonstrated that NRH,
another FGF target gene product, also regulates JNK
activity, Rho activity, and protrusive cell morphology.
In line with further elucidating the roles of FGF signaling
during gastrulation, it would be intriguing to determine
whether xANR5 and NRH interact functionally in these
events. The knockdown of xANR5 abolished tissue sep-
aration and active Rho could rescue the effect of
xANR5-MO, suggesting that Rho, an important regulator
of the cytoskeleton and cell migration, is required for
robust xANR5 activity during gastrulation. We further
demonstrated that xANR5 not only physically interacts
with PAPC through its C-terminal ankyrin repeats
domain, but also functionally interacts in the regulation
of JNK and Rho activity. The present work, which iden-
tifies a novel functional partner of PAPC in gastrulation
regulation, provides further insight into the in vivo role
and signaling mechanisms of the protocadherin family,
whose cytoplasmic complexes are mostly unknown.
Experimental Procedures
Embryos
Xenopus embryos were obtained by in vitro fertilization and staged
according to Nieuwkoop and Faber [24]. For each experiment, the
data from at least three different batches of embryos were collected.
Embryonic manipulation was carried out as described [12].
Antisense Morpholino Oligonucleotides
The antisense morpholino oligonucleotides (MOs) were obtained
from Gene Tools (Philomath, OR). The MO sequences were
as follows: xANR5-MO 50-CTAGTCTTTCTTCTACCTCTGCCAT-30;




Plasmid Construction and mRNA Preparation for Microinjection
A full-length cDNA clone, XL023o21, was isolated from XDB of the
NIBB/NIG Xenopus EST database, then inserted in-frame into the
EcoRI and XhoI sites of the pCS2+ plasmid by PCR. xANR5, includ-
ing the 50UTR, and xANR5 in which silent mutations were introduced
(a rescue construct, xANR5) were also inserted into the pCS2+ or
pCS2-Venus plasmid. GAL4-DBD-tagged c-jun (100 pg injected)
was a kind gift from M. Tada. Plasmids to be used for microinjection
were linearized with NotI, and capped mRNAs were synthesized as
described [12].
RNA Isolation and RT-PCR Analysis
Total RNA was isolated from 10 explants with Trizol reagent (Life
Technologies), according to the manufacturer’s instructions. Exper-
iments were carried out as previously described [7]. The gel images
were scanned and quantified with a FLA2000 Bioimager with built-in
software (Fuji Film, Japan).
Cytological Observation by Confocal Microscopy
To observe the subcellular localization of the Venus, RFP, myc, and
flag-tagged constructs, we used confocal laser scanning micros-
copy (Carl Zeiss MicroImaging) with built-in LSM 501 software.ACs isolated at the blastula stage were mounted on a glass-
bottomed dish (3910-035; Iwaki). DMZ or VMZ explants were
mounted on a glass-bottomed dish coated with fibronectin
(w4–10 mg/ml, F1141; Sigma-Aldrich), followed by incubation until
the proper stages. Immunostained explants were mounted on
a glass slide (Matsunami, JAPAN) or a glass-bottomed dish by
Gel/Mount (Biomeda, Foster City, CA). All images were prepared
for publication with Adobe Photoshop.
Cell Spreading, Single-Cell Protrusion, and Cell Dissociation
and Reaggregation Assay
DMZs isolated at stage 10.5 were dissociated in calcium-magne-
sium-free medium (CMFM). For the cell-spreading and -protrusion
assay, dissociated cells were plated on a fibronectin-coated
glass-bottomed dish, then cultured for an hour before observation.
The unattached cells were gently washed away. For the cell-spread-
ing assay, the morphology of cells attached to the fibronectin-
coated dish was examined by phase-contrast microscopy. We
counted the flattened cells that exhibited a multipolar cell shape
as spreading cells. To observe the membrane-protrusive morphol-
ogy, the behaviors of adherent cells were recorded as time-lapse
movies. For the dissociation and reaggregation assay, isolated
DMZs were gently rocked in CMFM for 1 hr, and then incubated
for 3 hr after 4 mM calcium was added to the CMFM.
JNK Assay and Rho Activation Assay
To examine JNK activity, ten ACs from embryos that had received
microinjections of GAL4-DBD-tagged c-jun (100 pg) with MO and/
or mRNA into two animal blastomeres at the 2-cell stage were
used. A mouse anti-GAL4-DBD antibody (Santa Cruz) and rabbit
anti-phospho c-jun antibody (Cell Signaling) were used to detect
the total c-jun and phosphorylated c-jun, respectively. The Rho
activation assay was carried out as described [21, 22] by a Rho
Activation Assay Biochem Kit (Cytoskeleton, CO).
Protein-Protein Interaction, SDS-PAGE, and Western Blotting
Epitope-fused proteins were harvested from 293T cells, then precip-
itated with a mouse anti-flag antibody (Sigma-Aldrich) or mouse
anti-GST antibody (Santa Cruz). SDS-PAGE and western blotting
were carried out as previously described [7, 12]. The antibodies
used in the western blotting were as follows: rabbit anti-GFP anti-
body (Molecular Biological Laboratories), mouse anti-myc antibody,
mouse anti-GST antibody (Santa Cruz), mouse anti-flag antibody
(Sigma-Aldrich), rabbit anti-flag antibody (Sigma-Aldrich), mouse
anti-Rho antibody (Clontech), and rabbit anti-RhoA (119) antibody
(Santa Cruz), HRP-conjugated anti-rabbit anti-IgG, and HRP-conju-
gated anti-mouse anti-IgG (Amersham). The ECL Plus kit (Amer-
sham) was used for detection.
Whole-Mount In Situ Hybridization and Immunohistochemistry
The embryos, explants, DIG (digoxigenin)-labeled RNA probes,
Fluorescein-labeled RNA probes, and epitope-tagged synthetic
mRNAs to be used for whole-mount in situ hybridization (WISH)
and immunostaining were prepared and used as described [12, 25,
26]. For the immunostaining, a mouse anti-myc antibody (Santa
Cruz) and a rabbit anti-flag antibody (Sigma-Aldrich) were used as
the primary antibodies. Alexa 488-labeled mouse anti-IgG antibody
(Molecular Probes) and Alexa 555-labeled rabbit anti-IgG antibody
(Molecular Probes) were used to detect the primary antibodies.
For the WISH, we used an alkaline phosphatase-conjugated anti-
fluorescein antibody (Roche) for Fluorescein-labeled probes and
an alkaline phosphotase-conjugated anti-DIG antibody (Roche) for
DIG-labeled probes. Embryos were stained with BCIP (Roche)
and BCIP+NBT (both from Roche) or BM Purple (Roche) in alkaline
phosphatase buffer.
Supplemental Data
Five figures are available at http://www.current-biology.com/cgi/
content/full/17/11/932/DC1/.
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